Byotrol Share Discussion Threads

[football] 24/8/2018 00:02

Byotrol makes good progress and a £4.5m acquisition

Hygiene specialist Byotrol enjoyed “a year of good progress”, it reported in its latest annual results to March 31.

The Daresbury-based company also announced the £4.5m acquisition of Kent-based Medimark Scientific.

Byotrol managed a small increase in revenues, from £3.127m to £3.140m, and an almost doubling of pre-tax losses, from £126,427 to £244,939.

However, chief executive David Traynor said it had managed to record its second consecutive profit at EBITDA level, after including R&D tax credits.

EBITDA was “significantly ahead of expectations,” the company said.

The firm’s financial strength was improved by a £4.6m equity capital raising in September, 2017, and net cash at the year end stood at £3.9m, compared with £951,000 the previous year.

Today’s statement said Byotrol now has “more than sufficient resources” to pursue its growth strategy.

In May this year the AIM-listed anti-microbial technology firm revealed it had received approval for its germ-killing product in the US, known as Byotrol24, and received its first orders to retail on online giant Amazon.

It is one of three strategic initiatives being followed by the company

Its Actizone initiative has been restructured, generating immediate cash from an IP sale, while retaining a substantial future upside for less resource input.

Byotrol24 is now under trial, which has been extended beyond the initial 10-week expected period.

And the firm’s alcohol-free hand sanitisers are now being sold into NHS and adjacent markets. There is substantial customer interest but resource requirements are higher and sales are slower than expected, the firm admitted.

The consumer and petcare segments are performing to plan, with significant growth opportunities, although the professional segment is behind plan, with new propositions now being developed and new alliance partners being sought.

Sevenoaks-based Medimark Scientific provides biocide-based infection control products into the animal and human healthcare markets.

It employs 14 staff and in the year to March 31, reported adjusted EBITDA of £380,000 on revenues of £2.7m.

There is an existing and long-standing relationship already in place between the two companies – Byotrol is currently a white label supplier of hand sanitisers to Medimark, which it sells under its Esense brand.

Commenting on the results and prospects, Byotrol chief executive David Traynor said: “This was another year of good progress, with further-improved operations and finances and our second ever profit at EBITDA level after including R&D tax credits.

“We continue with our excellent-science, technology-based strategy and are very confident in growth at home and overseas as the biocide regulatory changes bite.”

[cumnor] 23/8/2018 23:17

Agree slice, it would have been off the shelf in weeks (irrespective of agreements) had it not been generating some interest. A positive no matter the eventual outcome.

[slicethepie] 23/8/2018 21:51

Businesses such as target are pretty ruthless unlikely to give a second chance/ favour to a small co like Byotrol so inclined to view this as positive and suspect they want more sales data.

[football] 23/8/2018 20:36

gems everywhere but still can't get rid of the one above

[sikhthetech] 23/8/2018 19:47

slicethepie,

If a trial is extended, it could be because the sales figures haven't been convincing...
How much of a discount did BYOT give to Target to trial it's cleaner?.

[milesy] 23/8/2018 17:18

Footie - looks like it's complementary IP that Byotrol want to own and leverage in-house.

[football] 23/8/2018 14:55

1gw Speedos or Bermuda shorts? Can't wear Speedos anymore because I look like the bloke at the Southern Comfort advertThe new acquisition is it because of their products or is it maybe because if target take up our product we need to upscale manufacturing

[milesy] 23/8/2018 13:29

Byotrol24 selling for $4.29 in Target for just under 1 ltr:

Seems the company have been soliciting reviews (generally positive) with free samples.

Like the shape of today's results and acquistion.

[1gw] 23/8/2018 13:10

Nice surprise on my return from the beach! Good to see them get the results out today in the end and I like the fact that the acquisition shares are priced above 4p. Also I agree it sounds like good news that the Target trial is being extended - although I suppose it could mean the results are borderline and they need more time to decide whether it is going to be viable.

[greedfear] 23/8/2018 12:59

Sorry. Out again. Potentially paying 4.5 million for a company without equity and a profit of 218k (2018) (17k loss in 2017 and accumulated losses till 2017 of 227k) is a bit too generous imo.
BOL holders.

[slicethepie] 23/8/2018 12:41

Presumably must be going pretty well .....Now under trial under the brand 'Byotrol24' in US mass merchandiser Target. Trial now extended beyond the initial 10 week expected period.

[football] 23/8/2018 12:33

Just need a bit of news from the USA about the target trials and hopefully good news so we can start supplying all their stores

[maxk] 23/8/2018 12:20

Lets see .. but it sounds good.

[tanneg] 23/8/2018 11:54

Looks a good deal at first glance

Consideration of up to £4.5m is payable in respect of the Acquisition, which includes £0.4m of debt that Byotrol is assuming. Initial consideration of £2.3m is payable on completion, being £1.15m in cash and £1.15m from 28,048,780 new ordinary shares ("Ordinary Shares") being issued at 4.1p per share. An additional £1.8m of consideration is payable subject to achieving EBITDA targets in FYE 31 March 2019 and FYE March 2020. The deferred consideration is also to be paid half in cash and half in new ordinary shares.

[football] 23/8/2018 11:37

Well looks like results are out and looks like they are expecting growth and have the money to do so rather than just surviving along with an acquisition to help along with their expansion and growth.
Looks like a lot of works been going on in the background setting it all up so that's out they can carry out the business plan

[football] 23/8/2018 07:57

Looks like we've got a new mobile app lay out to advfn which is easier on the eye and looks to use aswell

[maxk] 22/8/2018 20:06

A serial disappointer.

However, miracles do happen..

[1gw] 22/8/2018 19:35

But releasing results on the Friday before the August bank holiday would suggest they were looking to bury them so I hope it is tomorrow.

[football] 22/8/2018 18:31

"Byotrol" or the "Company")

Notice of Results

Byotrol plc, the specialist anti-microbial technology company, announces that it will be releasing its audited results for the year ended 31 March 2018 no later than 24 August, 2018.

[1gw] 22/8/2018 17:25

Tomorrow then for the results?

[greedfear] 22/8/2018 12:05

One of my better decisions mud. I’ve made a good return on the money that became available because of selling BYOT. Again very interested in BYOT as it might be in for a rerate.

Edit: added some at close.

[mudbath] 21/8/2018 11:58

Hows your luck been greedfear ?

[greedfear] 18/8/2018 09:09

Have been out of this stock for over 4 years. Have been able to get in again at a lower price than my last sell then. I’m impressed with the progress (not revenuewise alas) that has been made since and the company financials are very sound (unlike then).
When I got out the enterprise value of BYOT was something like 8 million GBP, today it’s around 9 million GBP.
For all that has been accomplished since then (again not revenuewise) that’s a too low reward.
I’ve taken an initial position and will continue to add as long as progress is being made and the share price is below my exit prices.